Which statement aligns with CHRPE education?

Prepare for the NBEO Part III Test with comprehensive questions on Patient Encounters and Performance Skills. Answer multiple choice and scenario-based questions with explanations. Ensure success on your optometry exam!

Multiple Choice

Which statement aligns with CHRPE education?

Explanation:
CHRPE education centers on recognizing congenital hypertrophy of the retinal pigment epithelium as a benign, pigmented retinal lesion that is present from birth. This lesion is typically flat or only slightly elevated with sharp, well-defined borders and uniform pigmentation, sometimes showing lacunae that give a “bear tracks” appearance. It is usually unilateral and remains stable over time, and it does not involve inflammation, nor does it require steroids, surgery, or laser therapy. It is not a malignant tumor and not a vascular lesion. The key takeaway is its congenital, benign nature and the importance of distinguishing it from malignant or inflammatory conditions; in routine practice, CHRPE is often observed rather than treated, with attention to any changes that might suggest a different diagnosis.

CHRPE education centers on recognizing congenital hypertrophy of the retinal pigment epithelium as a benign, pigmented retinal lesion that is present from birth. This lesion is typically flat or only slightly elevated with sharp, well-defined borders and uniform pigmentation, sometimes showing lacunae that give a “bear tracks” appearance. It is usually unilateral and remains stable over time, and it does not involve inflammation, nor does it require steroids, surgery, or laser therapy. It is not a malignant tumor and not a vascular lesion. The key takeaway is its congenital, benign nature and the importance of distinguishing it from malignant or inflammatory conditions; in routine practice, CHRPE is often observed rather than treated, with attention to any changes that might suggest a different diagnosis.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy